The other cells in asthma: Dendritic cell and epithelial cell crosstalk

Current Opinion in Pulmonary Medicine

Volumn 9, Issue 1, 2003, Pages 34-41

  Lambrecht, Bart N ^a   Hammad, Hamida ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CYTOKINE;

ALLERGIC ASTHMA; CELL ACTIVITY; CELL FUNCTION; CELL HYPERPLASIA; CELL INTERACTION; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; CELL TYPE; CLINICAL FEATURE; DENDRITIC CELL; EPITHELIUM CELL; GOBLET CELL; HUMAN; INFLAMMATION; LYMPH NODE; MEDIATOR RELEASE; MUCOSA CELL; NONHUMAN; PATHOGENESIS; REVIEW; T LYMPHOCYTE; TH2 CELL;

ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CROSS REACTIONS; DENDRITIC CELLS; EPITHELIAL CELLS; MICE; RATS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TH2 CELLS;

EID: 0037212579     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-200301000-00006     Document Type: Review

References (84)

1. Wan H, Winton HL, Soeller C, et al.: Der P 1 facilitates transepithelial allergen delivery by disruption of tight junctions. J Clin Invest 1999, 104:123-133.
2. Rescigno M, Urbano M, Valzasina B, et al.: Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001, 2:361-367. This paper is the first description of constitutive expression of tight junction proteins by DCs. Although mainly derived from an in vitro co-culture system using Caco-2 cells, this might well be applicable to human airways.
3. Carayol N, Campbell AM, Vachier I, et al.: Modulation of cadherin and catenins expression by tumor necrosis factor-a and dexamethasone in human bronchial epithelial cells. Am J Respir Cell Mol Biol 2002, 26:341-347.
4. Schneeberger EE, Vu Q, LeBlanc BW, et al.: The accumulation of dendritic cells in the lung is impaired in CD18-/- but not in ICAM-1-/- mutant mice. J Immunol 2000, 164:2472-2478.
5. Sampath D, Castro M, Look DC, et al.: Constitutive activation of an epithelial signal transducer and activator of transcription pathway in asthma. J Clin Invest 1999, 103:1353-1361.
6. Kawaguchi M, Onuchic LF, Li X-D, et al.: Identification of a novel cytokine, ML-1, and its expression in subjects with asthma. J Immunol 2001, 167:4430-4435. The family of IL-17 related cytokines (IL-17, IL-17B, IL-17C, IL-25, ML-1) is rapidly expanding. These cytokines can directly modify epithelial cell function.
7. Lambrecht BN: Immunologists getting nervous: Neuropeptides, dendritic cells and T cell activation. Respir Res 2001, 2:133-138.
8. Dunzendorfer S, Kaser A, Meierhofer C, et al.: Cutting edge: Peripheral neuropeptides attract immature and arrest mature blood-derived dendritic cells. J Immunol 2001, 166:2167-2172.
9. Poynter ME, Irvin CG, Janssen-Heininger YMW: Rapid activation of nuclear factor-κB in airway epithelium in a murine model of allergic airway infiammtion. Am J Pathol 2002, 160:1325-1334. Using a NF-KB driven reporter gene luciferase it is shown that antigen exposure in sensitized mice leads to rapid upregulation of this transcription factor pathway.
10. Stacey MA, Sunday G, Vassali G, et al.: The allergen Der p1 induces NF-kB activation through interference with IkappaB alpha function in asthmatic bronchial epithelial cells. Biochem Biophys Res Commun 1997, 236:522-526.
11. Vliagoftis H, Befus AD, Hollenberg MD, et al.: Airway epithelial cells release eosinophil survival-promoting factors (GM-CSF) after stimulation of proteinase-activated receptor 2. J Allergy Clin Immunol 2001, 107:679-685.
12. Knight DA, Lim S, Scaffidi AK, et al.: Protease-activated receptors in human airways: Upregulation of PAR-2 in respiratory epithelium from patients with asthma. J Allergy Clin Immunol 2001, 108:797-803. There is an increased expression of PAR-2, but not PAR-4 in asthmatic epithelium. This is not downregulated by inhaled steroids.
13. Soumelis V, Reche PA, Kanzler H, et al.: Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 2002, 3:673-680. The IL-7 related cytokine TSLP stimulates DC maturation but also diminishes IL-12 production. In the presence of TSLP, produced in increased amounts in keratinocytes of atopic dermatitis patients, the DC is a Th2 stimulator.
14. de Jong EC, Vieira PL, Kalinski P, et al.: Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse th cell-polarizing signals. J Immunol 2002, 168:1704-1709. Different microbial patterns induce DCs to become either Th0, Th1 or Th2 stimulators. Even for Th2 induction the mechanisms by which this is accomplished are dependent upon the nature of the stimulus.
15. Propst S, Denson R, Rothstein E, et al.: Proinflammatory and Th2-derived cytokines modulate CD40-mediated expression of inflammatory mediators in airway epithelia: Implications for the role of epithelial CD40 in airway inflammation. J Immunol 2000, 165:2214-2221.
16. Kuperman DA, Huang X, Koth LL, et al.: Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat Med 2002, 8:885-889. Mice lacking STAT6 were protected from all pulmonary effects of IL-13. Reconstitution of STAT6 only in epithelial cells was sufficient for IL-13-induced AHR and mucus production in the absence of inflammation, fibrosis or other lung pathology
17. Mullings RE, Wilson SJ, Puddicombe SM, et al.: Signal transducer and activator of transcription 6 (STAT-6) expression and function in asthmatic bronchial epithelium. J Allergy Clin Immunol 2001, 108:832-838. This is the first description of the higher expression of STAT-6 in asthmatic epithelium.
18. Shim JJ, Dabbagh K, Ueki IF, et al.: IL-13 induces mucin production by stimulating epidermal growth factor receptors and by activating neutrophils. Am J Physiol Lung Cell Mol Physiol 2001, 280:L134-140.
19. Takeyama K, Fahy JV, Nadel JA: relation of epidermal growth factor receptors to goblet cell production in human bronchi. Am J Respir Crit Care Med 2001, 163:511-516.
20. Lordan JL, Bucchieri F, Richter A, et al.: Cooperative effects of Th2 cytokines and allergen on normal and asthmatic bronchial epithelial cells. J Immunol 2002, 169:407-414. Simultaneous exposure of bronchial epithelial cultures to IL-4 or IL-13 together with Der p 1 resulted in an increase in GM-CSF, IL-8, and TGF-α release which was only significant in epithelial cells derived from asthmatics.
21. de Saint-Vis B, Fugier-Vivier I, Massacrier C, et al.: The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. J Immunol 1998, 160:1666-1676.
22. hi cells.
23. Hurst SD, Muchamuel T, Gorman DM, et al.: New IL-17 Family Members Promote Th1 or Th2 Responses in the Lung: In Vivo Function of the Novel Cytokine IL-25. J Immunol 2002, 169:443-453. See [22••].
24. Upham JW, Denburg JA, O'Byrne P M: Rapid response of circulating myeloid dendritic cells to inhaled allergen in asthmatic subjects. Clin Exp Allergy 2002, 32:818-823. There is a rapid recruitment of myeloid DCs from the bloodstream following relevant allergen challenge of asthmatics. See accompanying editorial for more background on myeloid DCs in asthma.
25. Jahnsen FL, Moloney ED, Hogan T, et al.: Rapid dendritic cell recruitment to the bronchial mucosa of patients with atopic asthma in response to local allergen challenge. Thorax 2001, 56:823-826.
26. + DC subset-but which is devoid of myeloid or lymphoid differentiation potential.
27. + DC precursors in the bone marrow, due to a rise in serum eotaxin.
28. Wakahara S, Fujii Y, Nakao T, et al.: Gene expression profiles for FcepsilonRI, cytokines and chemokines upon FcepsilonRI activation in human cultured mast cells derived from peripheral blood. Cytokine 2001, 16:143-152.
29. Power CA, Church DJ, Meyer A, et al.: Cloning and characterization of a specific receptor for the novel CC chemokine MIP-3 alpha from lung dendritic cells. J Exp Med 1997, 186:825-835.
30. Reibman J, Hsu Y, Chen LC, et al.: Human Airway Epithelial Cells Release DC-Associated Chemokines; Role Of Inflammatory Stimuli And Ambient Particulate Matter [abstract]. Am J Respir Crit Care Med 2002, 165:A62.
31. McWilliam AS, Napoli S, Marsh AM, et al.: Dendritic cells are recruited into the airway epithelium during the inflammatory response to a broad spectrum of stimuli. J Exp Med 1996, 184:2429-2432.
32. Pichavant M, Tillie-Leblond I, Pestel J, et al.: Production of chemokines by allergen-stimulated bronchial epithelial cells induces the recruitment of dendritic cell precursors [abstract]. Am J Respir Crit Care Med 2002, 165:A482.
33. Stumbles PA, Strickland DH, Pimm CL, et al.: Regulation of Dendritic Cell Recruitment into Resting and Inflamed Airway Epithelium: Use of Alternative Chemokine Receptors as a Function of Inducing Stimulus. J Immunol 2001, 167:228-234.
34. Shortman K, Liu YJ: Mouse and human dendritic cell subtypes. Nature Rev Immunol 2002, 2:151-161.
35. Sallusto F, Lanzavecchia A: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alfa. J Exp Med 1994, 179:1109-1118.
36. Grouard G, Rissoan MC, Filgueira L, et al.: The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med 1997, 185:1101-1111.
37. +; unlike other dendritic cell subsets, however, they do not express CD8alpha or CD11b. These cells produce IFN alfa following viral infection in vivo.
38. Bjorck P: Isolation and characterization of plasmacytoid dendritic cells from FIt3 ligand and granulocyte-macrophage colony-stimulating factor-treated mice. Blood 2001, 98:3520-3526. FIt3L treatment expands mouse plasmacytoid DCs in vivo. In this way they can be purified
39. Cella M, Jarrossay D, Facchetti F, et al.: Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nature Med 1999, 5:919-923.
40. Gilliet M, Liu YJ: Generation of Human CD8 T Regulatory Cells by CD40 Ligand-activated Plasmacytoid Dendritic Cells. J Exp Med 2002, 195:695-704.
41. + T cell anergy by peripheral blood DC2 precursors. Eur J Immunol 2001, 31:2547-2557.
42. Rissoan MC, Soumelis V, Kadowaki N, et al.: Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999, 283:1183-1186.
43. +DCs, corresponding to Th2-inducing "DC2s," were found in PBMCs from atopic patients.
44. Uchida Y, Kurasawa K, Nakajima H, et al.: Increase of dendritic cells of type 2 (DC2) by altered response to IL-4 in atopic patients. J Allergy Clin Immunol 2001, 108:1005-1011.
45. Shodell M, Siegal FP: Corticosteroids depress IFN-alpha-producing plasmacytoid dendritic cells in human blood. J Allergy Clin Immunol 2001, 108:446-448. Steroid administration results in a decrease of IFN-alpha generation of approximately 25-fold, accompanied by reduction in circulating plasmacytoid dendritic cell numbers. This may be related to immunosuppression by DCs.
46. Jahnsen FL, Lund-Johansen F, Dunne JF, et al.: Experimentally induced recruitment of plasmacytoid (CD123high) dendritic cells in human nasal allergy. J Immunol 2000, 165:4062-4068.
47. Penna G, Sozzani S, Adorini L: Cutting edge: Selective usage of chemokine receptors by plasmacytoid dendritic cells. J Immunol 2001, 167:1862-1866.
48. Lambrecht BN, De Veerman M, Coyle AJ, et al.: Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation. J Clin Invest 2000, 106:551-559.
49. Lambrecht BN, Pauwels RA, Fazekas De St Groth B: Induction of rapid T cell activation, division, and recirculation by intratracheal injection of dendritic cells in a TCR transgenic model. J Immunol 2000, 164:2937-2946.
50. Lambrecht BN, Salomon B, Klatzmann D, et al.: Dendritic cells are required for the development of chronic eosinophilic airway inflammation in response to inhaled antigen in sensitized mice. J Immunol 1998, 160:4090-4097.
51. Julia V, Hessel EM, Malherbe L, et al.: A restricted subset of dendritic cells captures airborne antigens and remains able to activate specific T cells long after antigen exposure. Immunity 2002, 16:271-283. Elegant use of tetramers to detect Leishmania-specific Th2 cells in a mouse model of asthma. Elevated numbers of LACK-specific Th2 cells remained in the airways for 5 weeks after the last aerosol. Substantial numbers of DC presenting LACK peptides were found in the airways, but not in other compartments, for up to 8 weeks after antigen exposure.
52. Tunon de Lara JM, Redington AE, Bradding P, et al.: Dendritic cells in normal and asthmatic airways: expression of the alfa subunit of the high affinity immunoglobulin E receptor. Clin Exp Allergy 1996, 26:648-655.
53. Holloway JA, Holgate ST, Semper AE: Expression of the high-affinity IgE receptor on peripheral blood dendritic cells: differential binding of IgE in atopic asthma. J Allergy Clin Immunol 2001, 107:1009-1018. The expression of FcεRI on the surface of DCs from healthy and asthmatic subjects was not significantly different. However, in wvo, DCs from atopic asthmatic subjects had higher levels of receptor occupancy by IgE and bound exogenous IgE in vitro more efficiently than DCs from healthy subjects.
54. Gutzmer R, Langer K, Lisewski M, et al.: Expression and function of histamine receptors 1 and 2 on human monocyte-derived dendritic cells. J Allergy Clin Immunol 2002, 109:524-531.
55. Idzko M, la Sala A, Ferrari D, et al.: Expression and function of histamine receptors in human monocyte-derived dendritic cells. J Allergy Clin Immunol 2002, 109:839-846.
56. Caron G, Delneste Y, Roelandts E, et al.: Histamine Polarizes Human Dendritic Cells into Th2 Cell-Promoting Effector Dendritic Cells. J Immunol 2001, 167:3682-3686.
57. Mazzoni A, Young HA, Spitzer JH, et al.: Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization. J Clin Invest 2001, 108:1865-1873. Together with the three previous references, this paper shows that histamine inhibits IL-12 synthesis and increases IL-10 production in DCs. Monocyte-derived DCs express histamine receptors 1,2 and 3. The authors of the 4 papers disagree on the precise role of these receptors for the observed effects on IL-12 secretion.
58. Szeberenyi JB, Pallinger E, Zsinko M, et al.: Inhibition of effects of endogenously synthesized histamine disturbs in vitro human dendritic cell differentiation. Immunol Lett 2001, 76:175-182.
59. Bellinghausen I, Brand U, Knop J, et al.: Comparison of allergen-stimulated dendritic cells from atopic and nonatopic donors dissecting their effect on autologous naive and memory T helper cells of such donors. J Allergy Clin Immunol 2000, 105:988-996.
60. De Wit D, Amraoui Z, Vincart B, et al.: Helper T-cell responses elicited by Der p 1 -pulsed dendritic cells and recombinant IL-12 in atopic and healthy subjects. J Allergy Clin Immunol 2000, 105:346-352.
61. Hammad H, Charbonnier AS, Duez C, et al.: Th2 polarization by Der p 1 -pulsed monocyte-derived dendritic cells is due to the allergic status of the donors. Blood 2001, 98:1135-1141. Der p 1 induced an increase in CD86 and IL-10 expression only on DCs from HDM-sensitive patients. Purified T cells from house dust mite-sensitive patients stimulated by autologous Der p 1 -pulsed DCs preferentially produced IL-4 rather than IFN-γ. These effects were abolished in the presence of the inactive precursor of Der p 1 (ProDer p 1)
62. Hammad H, Lambrecht BN, Pochard P, et al.: Monocyte-derived dendritic cells induce a house dust mite-specific Th2 allergic inflammation in the lung of humanized SCID mice: Involvement of CCR7. J Immunol 2002, 169:1524-1534. This is the first demonstration that human DCs enhance Th2 type inflammation in vivo, using a humanized SCID model. Migration to the lymph nodes seems to be essential for these effects, as shown by blocking the CCR7 ligand SLC.
63. Harris NL, Watt V, Ronchese F, et al.: Differential T cell function and fate in lymph node and nonlymphoid tissues. J Exp Med 2002, 195:317-326. Activated T cells present in the lymph nodes could be stimulated by antigen to divide, produce effector cytokines, and migrate to peripheral tissues. By contrast, activated T cells that had migrated into nonlymphoid tissues (lung and airway) produced substantial effector cytokines upon antigen challenge, but were completely unable to divide or migrate back to the lymph nodes.
64. Cyster JG: Chemokines and cell migration in secondary lymphoid organs. Science 1999, 286:2098-2102.
65. Sallusto F, Lenig D, Mackay CR, et al.: Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998, 187:875-883.
66. Imai T, Nagira M, Takagi S, et al.: Selective recruitment of CCR4-bearing Th2 cells toward antigen- presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol 1999, 11:81-88.
67. Kim CH, Rott L, Kunkel EJ, et al.: Rules of chemokine receptor association with T cell polarization in vivo. J Clin Invest 2001, 108:1331-1339.
68. Panina-Bordignon P, Papi A, Mariani M, et al.: The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics. J Clin Invest 2001, 107:1357-1364. Endobronchial biopsies from asthmatics, taken 24 hours after allergen challenge, demonstrate that virtually all T cells express IL-4 and CCR4. CCR8 is coexpressed with CCR4 on 28% of the T cells, while CCR3 is expressed on eosinophils but not on T cells. Expression of the CCR4-specific ligands MDC and TARC is strongly upregulated on airway epithelial cells upon allergen challenge.
69. Gonzalo JA, Pan Y, Lloyd CM, et al.: Mouse monocyte-derived chemokine is involved in airway hyperreactivity and lung inflammation. J Immunol 1999, 163:403-411.
70. Sekiya T, Miyamasu M, Imanishi M, et al.: Inducible expression of a Th2-type CC chemokine thymus- and activation-regulated chemokine by human bronchial epithelial cells. J Immunol 2000, 165:2205-2213.
71. Campbell JJ, Brightling CE, Symon FA, et al.: Expression of chemokine receptors by lung T cells from normal and asthmatic subjects. J Immunol 2001, 166:2842-2848.
72. Hammad H, Smits HH, Wierenga EA, et al.: Monocyte-derived dendritic cells exposed to Der p1 allergen enhance the recruitment of Th2 cells: Major involvement of the chemokines TARC and MDC. Eur Cytokine Netw 2002, in press. Only in HDM-sensitive donor-derived DCs does Der p 1 induce the production of CCR4 ligands MDC and TARC. These chemokines contribute functionally to the attraction of Th2 clones in vitro.
73. + suppressor T cells: More questions than answers. Nat Rev Immunol 2002, 2:389-400.
74. Roncarolo MG, Levings MK, Traversari C: Differentiation of T Regulatory Cells by Immature Dendritic Cells. J Exp Med 2001, 193:F5-F10.
75. Dhodapkar MV, Steinman RM, Krasovsky J, et al.: Antigen-specific Inhibition of Effector T Cell Function in Humans after Injection of Immature Dendritic Cells. J Exp Med 2001, 193:233-238.
76. Bellinghausen I, Brand U, Steinbrink K, et al.: Inhibition of human allergic T-cell responses by IL-10-treated dendritic cells: differences from hydrocortisone-treated dendritic cells. J Allergy Clin Immunol 2001, 108:242-249.
77. + anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. Blood 2002, 99:2468-2476. Anergic T cells induced by IL-10-treated DCs express CTLA-4 and are able to suppress activation and function of T cells in an antigen-specific manner through cell contact inhibition of responding T cells.
78. + T cells responding to the chemokines CCL22, CCL17, I-309/CCL1, and to the virokine vMIP-I (ligands of CCR4 and CCR8). Dendritic cells may thus attract these cells into sites of inflammation.
79. Akbari O, DeKruyff RH, Umetsu DT: Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2001, 2:725-731. The first description that pulmonary DCs are able to transfer tolerance to inhaled antigen following exposure to inhaled allergens.
80. Akbari O, Freeman GJ, Meyer EH, et al.: Antigen-specific regulatory T cells develop via the ICOS ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat Med 2002, 8:1024-1032. Mature pulmonary dendritic cells in the bronchial lymph nodes of mice exposed to respiratory allergen induced the development of T(R) cells, in a process that required T-cell costimulation via the inducible costimulator (ICOS) ICOS-ligand pathway. The T(R) cells produced IL-10, and had potent inhibitory activity; when adoptively transferred into sensitized mouse T(R) cells blocked the development of AHR.
81. lo regulatory T cells, which confer protection against airway inflammation. This specific inhibition was mediated through IL-10 and transforming growth factor-beta.
82. McGuirk P, McCann C, Mills KH: Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: A novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J Exp Med 2002, 195:221-231. Filamentous hemaglutinin from Bordetella pertussis inhibited IL-12 and stimulated IL-10 production by DCs, and these DCs directed naive T cells into the regulatory subtype. The induction of Tr1 cells after interaction of a pathogen-derived molecule with cells of the innate immune system represents a novel strategy exploited by an infectious pathogen to subvert protective immune responses in vivo.
83. Umetsu DT, McIntire JJ, Akbari O, et al.: Asthma: An epidemic of dysregulated immunity. Nat Immunol 2002, 3:715-720.
84. Yazdanbakhsh M, Kremsner PG, van Ree R: Allergy, parasites, and the hygiene hypothesis. Science 2002, 296:490-494.